Misuse of antithrombotic therapy in atrial fibrillation patients: Frequent, pervasive and persistent

Journal of Thrombosis and Thrombolysis

Volumn 23, Issue 1, 2007, Pages 65-71

  Fornari, Luciana S ^a,c   Calderaro, Daniela ^a   Nassar, Ivana B ^a   Lauretti, Cristiane ^a   Nakamura, Lidia ^a   Bagnatori, Renato ^a   Ageno, Walter ^b   Caramelli, Bruno ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c NONE   (Brazil)

Author keywords

Anticoagulation; Antithrombotics; Atrial fibrillation; Embolic stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; TICLOPIDINE; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAZIL; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEATH; DRUG MISUSE; DRUG WITHDRAWAL; EMBOLISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAZIL; CARDIAC CARE FACILITIES; CROSS-SECTIONAL STUDIES; EMBOLISM; FEMALE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; THROMBOSIS;

EID: 33847004413     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-9012-9     Document Type: Article

References (45)

1. Ostranderld JR, Brandt RL, Kjelsberg MO, Epstein FH (1965) Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan. Circulation 31:888-898
2. Flegel KM, Shipley MJ, Rose G (1987) Risk of stroke in non-rheumatic atrial fibrillation [published erratum appears in Lancet 1987 Apr 11;1(8537):878]. Lancet 1:526-529
3. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: The Framinghan Study. Stroke 22:983-988
4. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM (1994) Prevalence of atrial fibrillation in the elderly subjects (the Cardiovascular Health Study). Am J Cardiol 74:236-241
5. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG (1995) Prevalence, age distribution and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 155:469-473
6. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention; the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 285:2370-2375
7. Phillips SJ, Whisnant JP, ÓFallon WM, Frye RL (1990) Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 65:344-359
8. Kannel WB, Abbott RD, Savage DD, McNamara PM (1983) Coronary heart disease and atrial fibrillation: The Framinghan Study. Am Heart J 106:389-396
9. Psaty BM, Manolio TA, Kuller LH, Kronmal LA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96:2455-2461
10. Kannel WB, Wolf PA, Benjamin EJ, Levi D (1998) Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N-9N
11. Wattigney WA, Mensah GA, Croft JB (2003) Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999. Circulation 108:711-716
12. Benjamin EJ, Wolf PA, D'Agostinho RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 98:946-952
13. Stewart S, Hart CL, Hole DJ, McMurray JJ (2002) A population-based study of the long term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 113(5):359-369
14. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A (1999) Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study. The College of French Cardiologists. Circulation 99:3028-3035
15. Wolf PA, Abbott RD, Kannel WB (1987) Atrial fibrillation: A major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 147:1561-1564
16. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE (1995) The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 98:476-484
17. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154:1449-1457
18. Hart RG, Halperin JL (1999) Atrial fibrillation and thromboembolism: A decade of progress in stroke prevention. Ann Intern Med 131:688-695
19. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB (1978) Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham study. Neurology 28:973-977
20. Petersen P, Boysen G, Gotfredsen J, Andersen ED, Andersen B (1989) Placebo controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1:175-179
21. Hart RG, Benavente O, McBride R, Pearce LA (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 131:492-501
22. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996; 348:633-638
23. Singer DE, Hylek EM (1995) Optimal oral anticoagulation therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischaemia. N Engl J Med 333:5-10
24. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC Jr, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. Circulation 104:2118-2150
25. Martinelli Filho M, Moreira DAR, Lorga A, Sosa E, Atie J, Pimenta J, Andrade JC, Fagundes ML, Kuniyoshi RR, Lorga Filho A, Lopes NA, Paola AA, Costa AB, Peres AK, Grupi CJ, Halperin C, Sternick E, Cruz FE, Darrieux FC, Lima GG, Jorge JC, Mateos JC, Oliveira JC, Zimerman LI, Scanavacca MI, Medeiros PT, Miranda RC, Costa R, Rassi SG, Galvão Filho SS, Tamer NS, Rodrigues TR (2003) Diretriz de Fibrilação Atrial. Arq Bras Cardiol 81(Suppl IV):1-24
26. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ (2004) Antithrombotic therapy in atrial fibrillation: The seventh ACCP conference on antithrombotic and trombolytic therapy. Chest 126:429S-456S
27. Gage BF, Boechler M, Doggette AL, Fortune G, Flaker GC, Rich MW, Radford MJ (2000) Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Stroke 31:822-827
28. Ibrahim SA, Kwoh K (2000) Underutilization of oral anticoagulant therapy for stroke prevention in elderly patients with heart failure. Am Heart J 140:219-220
29. McCormick D, Gurwitz JH, Goldberg RJ, Becker R, Tate JP, Elwell A, Radford MJ (2001) Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 161:2458-2463
30. Ageno W, Ambrosini F, Nardo B, Steidl L, Venco A (2001) Atrial fibrillation and antithrombotic treatment in italian hospitalized patients: A prospective, observational study. J Thromb Thrombolysis 12:225-230
31. Scott PA, Pancioli AM, Davis LA, Frederiksen SM, Eckman J (2002) Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients. Stroke 33:2664-2669
32. Blanch P, Freixa R, Ibernon M, Delso J, Salas E, Sobrepera JL, Padro J, Dos L, Codinach P (2003) Use of oral anticoagulants in patients discharged with atrial fibrillation in 2000. Rev Esp cardiol 56:1057-1063
33. Fang MC, Stafford RS, Ruskin JN, Singer DE (2004) National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med 164:55-60
34. Deplanque D, Corea F, Arquizan C, Parnetti J, Mas L, Gallai V, Leys D (1999) Stroke and atrial fibrillation: Is stroke prevention treatment appropriate beforehand? Heart 82:563-569
35. Glader EL, Stegmayr B, Norrving B, Terent A, Hulter-Asberg K, Wester PO, Asplund K (2004) Large variations in the use of oral anticoagulants in stroke patients with atrial fibrillation: A Swedish national perspective. J Intern Med 255:22-2
36. Bertolomeu Martinez V, Morillas Blasco PJ, Gonzalez Juanatey JR, Alegria Ezquerra E, Garcia Acuna JM, Gonzalez Maqueda I, Frutos Garcia A, Valero Parra R, Rodriguez Ortega JA (2002) Antithrombotic treatment in hypertensive patients with chronic atrial fibrillation. CARDIOTENS 99 study. Med Clin (Barc) 118:327-331
37. Lau E, Bungard TJ, Tsuyuki RT (2004) Stroke prophylaxis in institutionalized elderly patients with atrial fibrillation. J Am Geriatr Soc 52:428-433
38. Osseby GV, Benatru I, Sochurkova D, Urbinelli R, Megherbi SE, Couvreur G, Moreau T, Wolf JE, Giroud M (2004) Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997. From scientific evidence to practice. Prev Med 38:121-128
39. Deplanque D, Leys D, Parnetti L, Schimidt R, Ferro J, De Reuck J, Mas JL, Gallai V (2004) Stroke prevention and atrial fibrillation: Reasons leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol 57:798-806
40. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323:1501-1511
41. Stroke prevention in Atrial Fibrillation Study Final results. Circulation 1991; 84:527-539
42. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford JM (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators [published erratum appears in N Engl J Med 1993; 328(2):148]. N Engl J Med. 327:1406-1412
43. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C (1991) Canadian Atrial Fibrilation Anticoagulation (CAFA) Study. J Am Coll Cardiol 18:349-355
44. European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342:1255-1262
45. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI (1991) Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 68:41-46